{
    "organizations": [],
    "uuid": "e2ff2670acde6851599ed9ef79ead59b3904fdbf",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-revance-therapeutics-inc-announced/brief-revance-therapeutics-inc-announced-interim-8-week-phase-2a-results-for-rt002-in-treating-plantar-fasciitis-idUSFWN1P30LN",
    "ord_in_thread": 0,
    "title": "BRIEF-Revance Therapeutics Inc Announced Interim 8-Week Phase 2A Results For Rt002 In Treating Plantar Fasciitis",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Revance Therapeutics Inc:\n* REVANCE THERAPEUTICS INC - ANNOUNCED INTERIM 8-WEEK PHASE 2A RESULTS FOR RT002 IN TREATING PLANTAR FASCIITIS\n* REVANCE THERAPEUTICS INC - TRIAL‘S PRIMARY ENDPOINT SHOWED ROBUST IMPACT ON PAIN, WITH GREATER THAN 50% REDUCTION FOR PATIENTS TREATED WITH RT002\n* REVANCE THERAPEUTICS INC - RT002 APPEARED TO BE GENERALLY SAFE AND WELL-TOLERATED THROUGH WEEK 8\n* REVANCE THERAPEUTICS - EXPECT TO CONDUCT ANOTHER PHASE 2A TRIAL WITH MODIFIED DESIGN TO DEMONSTRATE RT002‘S ABILITY TO TREAT PLANTAR FASCIITIS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-08T21:21:00.000+02:00",
    "crawled": "2018-01-09T17:03:15.036+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "revance",
        "therapeutic",
        "inc",
        "revance",
        "therapeutic",
        "inc",
        "announced",
        "interim",
        "phase",
        "2a",
        "result",
        "rt002",
        "treating",
        "plantar",
        "fasciitis",
        "revance",
        "therapeutic",
        "inc",
        "trial",
        "primary",
        "endpoint",
        "showed",
        "robust",
        "impact",
        "pain",
        "greater",
        "reduction",
        "patient",
        "treated",
        "rt002",
        "revance",
        "therapeutic",
        "inc",
        "rt002",
        "appeared",
        "generally",
        "safe",
        "week",
        "revance",
        "therapeutic",
        "expect",
        "conduct",
        "another",
        "phase",
        "2a",
        "trial",
        "modified",
        "design",
        "demonstrate",
        "rt002",
        "ability",
        "treat",
        "plantar",
        "fasciitis",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}